Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94583572 | 9458357 | 2 | F | 20110829 | 20160823 | 20130814 | 20160929 | EXP | US-ROCHE-1002956 | ROCHE | 66.00 | YR | F | Y | 54.30000 | KG | 20160929 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94583572 | 9458357 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1184 MG | U | UNKNOWN | 125085 | 10 | MG | SOLUTION FOR INFUSION | |||||
| 94583572 | 9458357 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1150 MG | U | UNKNOWN | 125085 | SOLUTION FOR INFUSION | |||||||
| 94583572 | 9458357 | 3 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1148 MG | U | UNKNOWN | 125085 | SOLUTION FOR INFUSION | |||||||
| 94583572 | 9458357 | 4 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1134 MG | U | UNKNOWN | 125085 | SOLUTION FOR INFUSION | |||||||
| 94583572 | 9458357 | 5 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 1080 MG?LAST ADMINISTERED DATE: 22/AUG/2011 | U | UNKNOWN | 125085 | SOLUTION FOR INFUSION | |||||||
| 94583572 | 9458357 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Intravenous (not otherwise specified) | TOTAL DOSE ADMINISTERED: 100 MG. ALSO RECEIVED ON: 09/MAY/2011, 07/JUN/2011, 05/JUL/2011 AND 01/AUG/ | U | UNKNOWN | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94583572 | 9458357 | 1 | Ovarian cancer |
| 94583572 | 9458357 | 6 | Ovarian cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94583572 | 9458357 | OT |
| 94583572 | 9458357 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94583572 | 9458357 | Acute coronary syndrome | |
| 94583572 | 9458357 | Fracture | |
| 94583572 | 9458357 | Hip fracture | |
| 94583572 | 9458357 | Hypokalaemia | |
| 94583572 | 9458357 | Hyponatraemia | |
| 94583572 | 9458357 | Left ventricular dysfunction | |
| 94583572 | 9458357 | Lung infection | |
| 94583572 | 9458357 | Myocardial infarction | |
| 94583572 | 9458357 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94583572 | 9458357 | 1 | 20110411 | 0 | ||
| 94583572 | 9458357 | 2 | 20110509 | 0 | ||
| 94583572 | 9458357 | 3 | 20110607 | 0 | ||
| 94583572 | 9458357 | 4 | 20110705 | 0 | ||
| 94583572 | 9458357 | 5 | 20110801 | 20140416 | 0 | |
| 94583572 | 9458357 | 6 | 20110411 | 20140416 | 0 |